Recursion Pharmaceuticals recursionpharma.com


Public list: Digital Health (5963) Artificial Intelligence ( AI ) in Healthcare (362) Artificial Intelligence ( AI ) (3425) Pharma Startups (4732) AI 100 2018 (100) Clinical Trials Tech (192) Future of Pharma R&D (63) HLTH (200)

Recursion Pharmaceuticals leverages biological science, computation and artificial intelligence to provide a platform that discovers treatments for rare genetic disease and other conditions including aging, inflammation, infectious disease, oncology, and diagnostics, which can be modeled in human cells.

Recursion Pharmaceuticals leverages biological science, computation and artificial intelligence to provide a platform that discovers treatments for rare genetic disease and other conditions including aging, inflammation, infectious disease, oncology,...Show all

Company (Alive / Active)

Phone: 385-269-0203

Fax:

630 S. Komas Drive
Suite 300
Salt Lake City, 84108
Utah, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Recursion Pharmaceuticals $142.8M Nov 9, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Recursion Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 18 investors

Board Members

Competitors

Company Status Description Investors

Perlara

South San Francisco, California, United States
Alive / ActivePerlara, formerly Perlstein Lab, is a scientific discovery Public Benefit Corporation that works with patients and drug companies to find treatments for diseases previously believed to be too rare to cure and to uncover underlying mechanisms that enable the development of treatments that work across a range of diseases and individuals.Login to see details

Patents

Title Application Date Patent Date Status
(Patent / Application)